cf-TNA (cell-free, 52 genes) pan-cancer, NGS

CMDL > cf-TNA (cell-free, 52 genes) pan-cancer, NGS

Intended Use

The cf-TNA (cell-free, 52 genes) pan-cancer, NGS intended for detecting genetic alterations in cell-free DNA (cfDNA) and RNA.
Specimen Required

Lavender (EDTA), pink (K2EDTA)

Patient Preparation
  • Sample Collection: 2 Tubes / EDTA Blood / 2 mL per tube
  • Specimen Preparation: Do not freeze. Transport 3 mL whole blood. (Min: 1 mL)
  • Storage/Transport Temperature: Refrigerated
  • Unacceptable Conditions
    • Plasma or serum.
    • Heparinized specimens.
    • Frozen specimens in glass collection tubes.
  • Remarks: –
  • Stability: Ambient: 72 hours; Refrigerated: 1 week; Frozen: 1 month.
Methodology

Massively Parallel Sequencing: Comprehensive analysis of tumor-derived DNA and RNA, detecting multiple types of genetic alterations across more than 50 cancer-related genes, including: Single nucleotide variants (SNVs), Insertions/deletions (INDELs), Copy number variants (CNVs) and Gene fusions.

Sample Received to Report Turnaround Time (TAT)

Twice in a week (Scheduled Test)

Reference Interval

–

Interpretive Data

Refer to the report.

Resources

  • Additional Technical Information
  • Test Request Form

Sample Reports

  • Enhanced Report
  • See report